WallStreetZenWallStreetZen

NASDAQ: LIXT
Lixte Biotechnology Holdings Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Lixte Biotechnology Holdings earnings were -$4.1M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest LIXT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$2.0M, up 161.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LIXT reported annual earnings of -$3.6M, with -29.5% growth.

LIXT earnings history

Current Revenue
$0.0
Current Earnings
-$4.1M
Current Profit Margin
0%

LIXT Return on Equity

Current Company
-219%
Current Industry
-21.3%
Current Market
35.2%
LIXT's Return on Equity (-219%)... subscribe to Premium to read more.
High Return on Equity Performance

LIXT undefined

Current Company
-178.1%
Current Industry
-8.8%
LIXT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LIXT announces earnings.

LIXT undefined

Current Company
-82.92%
Current Industry
-3.4%
LIXT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LIXT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LIXT-$4.07M-$4.13MN/A-$1.18
LIMNN/AN/AN/AN/A
CVKD-$14.38M-$14.39MN/A-$8.01
ENLV-$14.51M-$12.70MN/A-$0.55
NNVC-$7.44M-$8.13MN/A-$0.51
View Top Biotech Stocks

Lixte Biotechnology Holdings Earnings Reports & History FAQ

What were Lixte Biotechnology Holdings's earnings last quarter?

Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q3 2025 earnings per share (EPS) of -$0.33, up 25% year over year. Total LIXT earnings for the quarter were -$2.03 million. In the same quarter last year, Lixte Biotechnology Holdings's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Lixte Biotechnology Holdings stock.

Is Lixte Biotechnology Holdings profitable or losing money?

As of the last Lixte Biotechnology Holdings earnings report, Lixte Biotechnology Holdings is currently losing money. Lixte Biotechnology Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$4.08 million, a 2.07% increase year over year.

What was LIXT's earnings growth in the past year?

As of Lixte Biotechnology Holdings's earnings date in Q4 2025, Lixte Biotechnology Holdings's earnings has grown year over year. LIXT earnings in the past year totalled -$4.13 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.